Clinical Trials Logo

Heart Defects, Congenital clinical trials

View clinical trials related to Heart Defects, Congenital.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06223321 Active, not recruiting - Clinical trials for Congenital Heart Diseases

The Role of Multislice Computed Tomography in Congenital Heart Diseases in Paediatric Age Group.

Start date: January 3, 2023
Phase:
Study type: Observational

This study aims to evaluate the added value of cardiac multislice Computed Tomography in assessment of CHD in pediatrics as a non-invasive presurgical planning method

NCT ID: NCT06076395 Active, not recruiting - Clinical trials for Cardiac Congenital Defects

Volume Versus Pressure Ventilation on Lung Atelectasis

Start date: January 12, 2024
Phase: N/A
Study type: Interventional

This prospective randomized comparative study, to assess post-operative lung atelectasis by comparing calculated lung score using ultrasound between pediatric patients intubated with LMA (laryngeal mask airway) under volume versus pressure controlled modes of ventilation.

NCT ID: NCT06031831 Active, not recruiting - Clinical trials for Congenital Heart Disease

Analysis of Risk Factors and Prognosis of Pediatric Patients After Operations for Congenital Heart Disease

Start date: May 15, 2022
Phase:
Study type: Observational [Patient Registry]

This hospital-based retrospective study reviewed patients who underwent surgery for CHD between 2017 and 2020 and analyzed the clinical features and outcomes associated with airway anomalies.

NCT ID: NCT05378685 Active, not recruiting - Clinical trials for Congenital Heart Disease

Nasal vs. Oral Intubation for Neonates Requiring Cardiac Surgery

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Often, infants struggle to feed orally after surgery for congenital heart disease and may require supplemental feeding interventions at discharge. In this study, the investigators prospectively randomize infants to oral or nasal endotracheal intubation for surgery and assess postoperative feeding success.

NCT ID: NCT05257525 Active, not recruiting - Clinical trials for Cardiopulmonary Bypass

Impact of Chest Wall Mechanics on Lung and Cardiovascular Function During Delayed Sternal Closure

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

This study aims to describe chest wall mechanics during delayed sternal closure (DSC) in neonates following cardiopulmonary bypass or palliation of congenital heart diseases.

NCT ID: NCT04907526 Active, not recruiting - Clinical trials for Congenital Heart Disease, SRV Dependent

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Start date: June 1, 2021
Phase: Phase 1
Study type: Interventional

Researchers want to better understand what happens to the heart when the autologous (from one's own body) stem cells are injected directly into muscle of the right side of the heart during the Fontan (Stage III) surgery. They want to see if there are changes in the electrical activity, the structure, and the function of the heart following this stem cell-based therapy. Researchers will compare the results from people who receive the stem cells to the results from people who do not receive the stem cells.

NCT ID: NCT04787705 Active, not recruiting - Cardiac Surgery Clinical Trials

Multicenter Validation of a Predictor Model of ACHD Patients and Cardiac Surgery

Start date: March 10, 2020
Phase:
Study type: Observational

This multicentre study is to validate prediction modeling for the ACHD population undergoing cardiac surgery. The validation of this prediction model will support and generalize its use as a risk stratification tool in the ACHD population.

NCT ID: NCT04769167 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes

CHARMED
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Beyond EV-B, there are clinical observations to implicate other viruses in birth defects, including CHD. Since the Rubella epidemic of 1960s', however, viruses have received little attention and certainly no comprehensive study, especially using next generation sequencing (NGS), has been undertaken in this context. The current pandemic as well as those caused by Zika, influenza, Ebola and Lassa Fever (among many) have shown pregnant women and their baby are at high risk. Therefore, an open-minded approach is warranted when considering the role of maternal viral infections in CHD. Even less is known about maternal immune response, such as antibody production, to these viruses. The investigator's goal is to answer the above gaps in knowledge. The investigators propose to do that using two different approaches; one retrospective (analysis of samples in two existing, large biorepositories) and the other prospective. The investigator's have created a multi-disciplinary team to bring together the needed expertise from individuals who have overlapping and vested interest in this project. The investigator's specific aim is to examine the diversity of the gut virome in non-pregnant and pregnant women with and without diabetes, with special emphasis on known cardiotropic viruses (those with tropism for cardiac tissues). This study is seen by the investigator's as the first step prior to a larger prospective multi-institutional study to specifically assess the linkage between the maternal virome and CHD pathogenesis.

NCT ID: NCT04667455 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Improving Care for Children With Congenital Heart Disease.

Start date: February 17, 2020
Phase: N/A
Study type: Interventional

Establish a cardiovascular biomarker profile to help screening for congenital heart disease in infants and children as well as use non-invasive cardiac imaging in combination with such profiling to better predict the need for future cardiac interventions such as open heart surgery or cardiac catheter intervention selected types of with congenital heart disease.

NCT ID: NCT04631965 Active, not recruiting - Diabetes Clinical Trials

Healthcare Transition of Adolescents With Chronic Health Conditions

Start date: September 1, 2017
Phase:
Study type: Observational

At least 12% of children have a chronic disease that requires regular medical follow-up after patients reach legal maturity. This international study aims to provide prospective evidence for improving health and wellbeing outcomes in this population. The primary hypothesis is that transition readiness will be more strongly associated with adherence to follow-up, fewer emergency visits and continued education than disease severity or chronological age. The secondary hypothesis is that positive experiences of care will be associated with lower levels of anxiety. Positive care experiences and low anxiety will predict better health-related quality of life during the transition period. A cohort of 504 young patients will be followed for three years. Patients have been recruited from pediatric hospitals 0-12 months prior to the transfer of care and follow-up will be completed after the patients have been followed for two years in adult healthcare.